It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

vaccinations

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Australia hits 'magnificent milestone' with 80% rate of vaccinations

Asia Pacific Nov 6, 2021

Australia hits 'magnificent milestone' with 80% rate of vaccinations

Once a champion of a "COVID-zero" strategy to manage the pandemic, the country of 25 million has moved toward living with the virus through extensive vaccinations.

Pfizer results open door to new chapter for COVID treatments

World / Science & Health | ANALYSIS Nov 6, 2021

Pfizer results open door to new chapter for COVID treatments

by Emma Court and Fiona Rutherford

The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.’s and Merck & Co. Inc.’s new pills may be just that. But questions remain about their safety and how well they will work.

Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%

World / Science & Health Nov 5, 2021

Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%

by Robert Langreth

The drugmaker claims "overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.

Lessons ASEAN could learn from Malaysia’s pandemic success

Commentary / World Nov 5, 2021

Lessons ASEAN could learn from Malaysia’s pandemic success

by Joshua Kurlantzick

Malaysia has fully vaccinated more than 77% its population, with some 90% of adults — those deemed eligible for the vaccine — receiving a second dose.

Japan's Takara Bio to produce mRNA vaccines possibly from January

National / Science & Health Nov 4, 2021

Japan's Takara Bio to produce mRNA vaccines possibly from January

At present, Japan completely depends on imports for its coronavirus vaccine supply.

From Boeing to Mercedes, a U.S. worker rebellion swells over vaccine mandates

Business | FOCUS Nov 3, 2021

From Boeing to Mercedes, a U.S. worker rebellion swells over vaccine mandates

The mandate has stirred protests from workers in industries across the country, as well as from Republican state officials.

South Korea eases curbs and introduces vaccine passports in 'living with COVID-19' campaign

Asia Pacific Nov 1, 2021

South Korea eases curbs and introduces vaccine passports in 'living with COVID-19' campaign

The first phase of the revised rules is due to last for a month, with plans to scrap all restrictions by February.

Pfizer won the first round, but Moderna sees final victory ahead

World Oct 30, 2021

Pfizer won the first round, but Moderna sees final victory ahead

by Robert Langreth and Riley Griffin

Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company’s mRNA technology gives it an advantage.

Pfizer shot cleared for U.S. kids 5 to 11 in pandemic milestone

World Oct 30, 2021

Pfizer shot cleared for U.S. kids 5 to 11 in pandemic milestone

The emergency authorization brings the U.S. a step closer to shots being administered at schools, pediatricians’ offices and pharmacies around the country.

Japan to open up COVID-19 booster shots to all residents

National Oct 28, 2021

Japan to open up COVID-19 booster shots to all residents

by Kanako Takahara

The policy differs from that of other nations, where the shots are mainly being limited to older people, health care workers and those with pre-existing conditions.

Japan’s vaccination rate hits G7 milestone but may top out at 80%

National | FOCUS Oct 27, 2021

Japan’s vaccination rate hits G7 milestone but may top out at 80%

by Osamu Tsukimori

The nation is now ranked No. 3 for its vaccination rate among the Group of Seven industrialized countries, after only Canada and Italy.

Unvaccinated players may be able to compete at Australian Open

Tennis Oct 25, 2021

Unvaccinated players may be able to compete at Australian Open

Unvaccinated players will need to complete 14 days of quarantine and undergo regular testing.

« 1 … 18 19 20 … 74 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times